Skip to main content
Clinical Trials/NCT06161935
NCT06161935
Completed
Not Applicable

A Retrospective Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer Involving Patients in Thoracic Surgery Fudan University Shanghai Cancer Center From April 2008 to July 2022. Data Were Analyzed From October 2022 to July 2023 to Further Elaborated the Different Nodal Metastatic Pattern in Different Tumors and Identify the Characteristics of Patient Group Without Lymph Node Metastasis.

Fudan University0 sites7,067 target enrollmentApril 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer Non Small Cell
Sponsor
Fudan University
Enrollment
7067
Primary Endpoint
The number of participants with no mediastinal lymph metastases after systematic lymph node dissection.
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to learn about in invasive non-small cell lung cancer patients who underwent pulmonary resection with systematic lymph node dissection from April 2008 to July 2022 . The main question it aims to answer are: determine the situation of zero risk mediastinal lymph metastases and the different lymph node metastatic patterns of tumors with different characteristics.

Participants will provide personal information to analyze. and there is not a comparison group.

Registry
clinicaltrials.gov
Start Date
April 2008
End Date
July 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Penghao Deng

Principal Investigator

Fudan University

Eligibility Criteria

Inclusion Criteria

  • invasive non-small cell lung cancer patients in FUSCC who underwent pulmonary resection with systematic lymph node dissection from April 2008 to July 2022

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The number of participants with no mediastinal lymph metastases after systematic lymph node dissection.

Time Frame: 1 year

We counted the number of participants with no mediastinal lymph metastases after systematic lymph node dissection and tried to determine the situation of zero risk mediastinal lymph metastases after our analyses.

Similar Trials